What if you'd held IBRX?
A $1,000 investment in ImmunityBio, Inc. (IBRX) at the month-end close of 2015-07 would be worth $282 at the close of 2026-09 — -71.8% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $4,436.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $330 | -67.0% |
| 2017 | $259 | -21.5% |
| 2018 | $66.94 | -74.2% |
| 2019 | $219 | +226.7% |
| 2020 | $769 | +251.7% |
| 2021 | $351 | -54.4% |
| 2022 | $293 | -16.6% |
| 2023 | $290 | -1.0% |
| 2024 | $148 | -49.0% |
| 2025 | $114 | -22.7% |
| 2026 | $498 | +335.9% |
Best and worst month-end to buy
The best single month-end close to have bought IBRX was 2019-06 ($1.02): $1,000 then is $8,461 today. The worst was 2021-02 ($32.51): $1,000 then is $265.
FAQ
What would $1,000 in IBRX be worth today?
A $1,000 investment in ImmunityBio, Inc. (IBRX) at the start of 2015 would be worth about $282 today, a total return of -71.8%. Dividends are reinvested in these figures.
What were the best and worst years for IBRX?
ImmunityBio, Inc. (IBRX)'s strongest calendar year since 2015 was 2026, a +335.9% return — $1,000 held through that year became about $4,359 by year-end. Its weakest year was 2018, at -74.2%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in IBRX have grown?
Investing $100 at the end of every month since 2015-07 would have grown to about $31,932 on $13,500 invested.
Did IBRX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $4,436. IBRX trailed the S&P 500 by +93.6% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
ImmunityBio, Inc. (IBRX) historical total-return data from 2015-07 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-23. Not financial advice.